Back to Ask the Diabetes Team Ask the Diabetes Team

From Emmaus, Pennsylvania, USA:

Is there any difference in the latest FDA approved short-acting insulin Apidra versus Humalog and NovoLog?


Apidra (glulisine generically) is the newest fast-acting human insulin analog. Much like NovoNordisk's NovoLog (aspart insulin) and Lilly's Humalog (lispro insulin). There is not much practical experience yet. Research reports are also not very extensive, but Apidra is made by Aventis and will soon be on the United States' and world markets. Word of mouth from diabetologists is that it is, so far, quite similar to Novolog and Humalog, though it will take two or three years for enough experience to accumulate to know how similar or dissimilar it actually is as folks start to use it.


Original posting 30 May 2004
Posted to Insulin


  Back to Ask the Diabetes Team Return to the Top of This Page

Last Updated: Tuesday April 06, 2010 15:09:58
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.